Thank You!
Thank you for your email subscription. Check your email to get Coupon Code.
Marketing Mix (4Ps) Analysis of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
Posted by Addison on Jul-19-2022
About 4Ps Model
The 4p model of marketing comprises elements of the product, price, promotion, and place (Chernev, 2018; Kucuk, 2017). The model is commonly referred to as the marketing mix. The marketing mix of the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology allows and facilitates it in achieving its marketing objectives as well as in positively influencing the target audience (Baines, Fill, & Rosengren, 2017). The elements identified in the marketing mix are typically used by the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology for marketing its product and service, and for brand development and building activities. These elements are critically fundamental for the development and creation of marketing plans and marketing strategies by the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology – especially for developing and sustaining competitive advantage (Chernev, 2018; Stead & Hastings, 2018; Grewal & Levy, 2021). Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures that the elements identified for the marketing mix model work together cohesively, and complement each other in all its marketing strategies and plans (Abratt & Bendixen, 2018; Deepak & Jeyakumar, 2019).
Product
The product refers to the actual good or service that is being marketed to the consumers by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology, and which will be consumed by the target audience of the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Groucutt & Hopkins, 2015). The product or the service being offered by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology largely aims to fulfill a market need and demand, as well as works to create demand by providing a unique and fulfilling customer experience (Stead & Hastings, 2018; Sahaf, 2019).
Quality
Product quality for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology largely refers to how well the company is able to satisfy the customers’ needs and demands through its product and service offerings (Baines, Fill, & Rosengren, 2017; Deepak & Jeyakumar, 2019). In addition to this, the product quality for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology further includes the adherence of the company and its product and service offerings to industry standards and benchmarks as well as the ability of the same to serve its meaning and purpose comprehensively (Iacobucci, 2021; Groucutt & Hopkins, 2015; Chernev, 2018).
Customer demand fulfillment
The ability of the product and service to fulfill customer demands as well as its purpose, and to work efficiently and effectively are important facets of product quality for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Iacobucci, 2021; Deepak & Jeyakumar, 2019). Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures that its products are available for customers at affordable prices by controlling internal costs (Wu & Li, 2018).
Warranty
The warranty extended by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology includes the guarantee that the company to its customers regarding the functioning and the quality of the purchased food and service (Abratt & Bendixen, 2018). In addition, Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology’s warranty also includes any compensation that the company has promised to give the customers in case the product and service fall short of the marketed benefits and functionalities (Išoraitė, 2016; Grewal & Levy, 2021; Kucuk, 2017).
Packaging
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology focuses thoroughly on the packaging and makes sure it includes the process of designing, evaluating, and developing a container for the products and services being manufactured and marketed (Deepak & Jeyakumar, 2019; Baines, Fill, & Rosengren, 2017). The packaging of the product and the service allows Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to highlight the product's purpose, as well as provides ease in transportation, gives room for more prolonged shelf life, and creates a unique and delightful customer experience (Kareh, 2018; Park, 2020).
Brand
The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology invests in developing brands out of its products and service offerings. This means that the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology engages in brand-building activities for its offerings i.e. associating specific designs and communications with its products to ensure differentiation, and easier communication with the target audience (Gillespie & Swan, 2021).
Building the brand
The branding-building activities undertaken by the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensure that its target audience is better able to relate to the offerings (Abratt & Bendixen, 2018). Through this, the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures higher loyalty and repeat purchases, as well as positive perception creation for its offerings (Khan, 2014; Kareh, 2018).
Features
Product features or characteristics refer to the product traits and attributes present in the offerings of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology that allow the company to successfully deliver unique value to customers through the products and services manufactured and offered (Varadarajan, 2015; Kotler & Keller, 2021). The product traits and features also allow Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to create points of differentiation from the competition for its offering (Kotler & Keller, 2021; Park, 2020).
Product style
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology makes sure to focus on the design and the look of the product, and the ability of the same to meet the expectations and lifestyle of the target audience (Groucutt & Hopkins, 2015). The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures that the product style and design complement its features and purpose.
Functionality
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology makes sure that the product manufactured fulfills its purpose, and meets customer expectations (Abratt & Bendixen, 2018). Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology focuses on the product design, and how well it is able to fulfill the demands of the customers, as well as fill in the market gap (Baines, Fill, & Rosengren, 2017)
Experience
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology products provide the customers with an exceptional and unique experience upon consumption (Kotler & Keller, 2021). This experience includes interaction with the products that leads to different unique and positive customer feelings and helps the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology maintain differentiation from the competition (Varadarajan, 2015; Kotabe & Helsen, 2020).
Availability
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures that its product and service offerings are available for its target consumers at various retail setups. The easy availability ensures that consumers are able to purchase the offerings of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology from various locations, allowing the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to create an advantage over competing players (Kotler & Keller, 2021; Chernev, 2018).
Convenience
One point of focus for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology in its product offering is convenience. The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures that its products and service are easy and convenient to use. The factor of convenience allows Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to enjoy a higher consumption rate, as well as increased sales and trials (Kotabe & Helsen, 2020; Kucuk, 2017).
After-sales service
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology caters to after-sales queries and demands of customers, which also includes processes of returns as well as exchanges. The after-sales service of company Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology is detrimental and critical in determining customer satisfaction with its offerings (Iacobucci, 2021; Chernev, 2018).
Sizes
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology has different SKUs in the product available. Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology has its products available in various SKU sizes which helps the company boost its sales, as different customer groups have different demands for the product quantity – depending on their usage, income as well as lifestyle (Grewal & Levy, 2021; Deepak & Jeyakumar, 2019).
Price
The element of price in the marketing mix refers to the value that customers pay for the service or the product offered by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology. The pricing strategy and the price of the offerings are critical because it determines three success for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology by directly influencing the profit levels and revenue for the company (Kotabe & Helsen, 2020; Kotler & Keller, 2021; Deepak & Jeyakumar, 2019).
Discounts
One of the ways through which the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology influences its pricing strategies is through offering discounts on its product and service offerings. Discounted pricing for the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology means that Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology decreases the price of the product and service in order to generate interest, or even unload excessive inventory and stock; as well as for boosting sales (Baines, Fill, & Rosengren, 2017).
Margins
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology makes room for margins through the additional value charged in price over the cost – which allows the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to build profit for its offerings (Kucuk, 2017). The margins available to the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology largely depend on the offering and its quality itself, in addition to the brand equity and brand value of the company.
Payment method
A significant factor of the pricing element of the marketing mix for the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology includes the payment methods that the company offers (Kotler & Keller, 2021; Abratt & Bendixen, 2018). Since the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology largely operates distribution to retail via agents and retailers, it ensures the inclusion of different payment methods. This includes digital payment, cash payment, as well as credit allowances (Grewal & Levy, 2021; Groucutt & Hopkins, 2015).
Pricing strategy
Penetrative pricing strategy
For Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology, the penetrative pricing strategy is adopted as it allows the company higher trial generation of its products and services in the desired target market, as well as allows the building of a broader reach for its product offerings by ensuring easier affordability (Baines, Fill, & Rosengren, 2017).
Introductory pricing strategy
For new products that the company launches, Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures to adopt an introductory pricing strategy. This means that the company prices its products and service offerings at relatively lower prices than the competition. This introductory pricing strategy allows the company to increase trial generation, achieve higher penetration, as well as lead to the generation of increased brand awareness and recall (Kucuk, 2017).
Aggressive/competitive pricing strategy
For existing products, Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology uses a competitive and aggressive pricing strategy. This ensures that the products are available readily at competitive prices. Aggressive and competitive pricing strategies allow the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to experience high rates of growth and experience by allowing the buildup of consumer loyalty and following based largely on product attributes and quality instead of price– leading to the generation of higher brand equity and value for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Deepak & Jeyakumar, 2019).
Place
The element of place within the 4Ps model of the marketing mix largely refers to the locations where company Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology stocks its product and service offerings for consumers' accessibility and purchase. Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology ensures to include all possible placements which are easily accessible to and available for the company's target audience (Iacobucci, 2021; Išoraitė, 2016). With the advancement of technology, Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology has expanded the placement of its products beyond the traditional brick-and-mortar retail spaces, to include modern Omni channel retail platforms as well (Iacobucci, 2021).
Physical stores/retail
The physical retail and stores i.e. the traditional brick and mortar spaces continue to be the prioritized locations for product placement by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Iacobucci, 2021; Groucutt & Hopkins, 2015; Abratt & Bendixen, 2018).
Retail types
These include hypermarkets, upper markets, and smaller grocery stores - all of which allow increased accessibility and availability of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology’s products and services to its target audience. Physical retail has a higher footfall and allows direct interaction of the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology brand and its product offerings with the consumers (Groucutt & Hopkins, 2015; Groucutt & Hopkins, 2015; Chernev, 2018).
E-commerce
E-tailers
The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also stocks its products on e-commerce retail shops – such as amazon. This allows the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology higher access and penetration in other markets, as well as in secondary consumer groups. Moreover, e-commerce retailing is more cost-effective for the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Wu & Li, 2018; Chernev, 2018; Baines, Fill, & Rosengren, 2017).
Company-owned website
In addition to stocking products with other e-trailers, the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also manages orders through its own website, where consumers can place orders for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology’s products directly. This allows the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology greater control over stock and inventory management, as well as distribution networks – allowing the buildup of stronger relations with consumers.
Lastly, the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also takes limited orders through social media pages and platforms (Wu & Li, 2018; Baines, Fill, & Rosengren, 2017).
Aggregators
Another way through which Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology uses e-commerce is by stocking its offerings with aggregators (Kucuk, 2017). This allows the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to maximize its reach and increase penetration. At the same time, it also allows increased trial generation and repeats purchases for the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology product offerings (Išoraitė, 2016; Groucutt & Hopkins, 2015).
Specialty stores
Interestingly, the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also stocks its products with specialty stores (Grewal & Levy, 2021). This gives the company direct exposure to its target market and audience and allows the consumers to directly interact with the brand and its offerings- without too much clutter (Kotler & Keller, 2021; Gillespie & Swan, 2021). The specialty stores are located in prime locations, and allow Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology higher penetration and reach, leading to increased brand awareness for its product offerings (Groucutt & Hopkins, 2015; Išoraitė, 2016).
Direct sales
The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also has a trained sales team for making direct sales (Kotler & Keller, 2021). Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology targets not only B2C consumers but also B2-B consumers (Chernev, 2018; Grewal & Levy, 2021). Both these categories, also make use of direct marketing whereby the sales agents and teams visit the target audience and business directly and detail the product features and benefits (Kotler & Keller, 2021; Groucutt & Hopkins, 2015).
B2B and direct sales
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology’s team makes sales instantly during field visits for the company (Sahaf, 2019; Stead & Hastings, 2018). The target audience is carefully profiled and selected by the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology so that the sales representatives are able to filter out the clutter (Gillespie & Swan, 2021; Išoraitė, 2016). Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology is able to easily contact and communicate with the desired business groups only (Groucutt & Hopkins, 2015; Abratt & Bendixen, 2018).
Inventory management
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology effectively manages its inventory and fulfills the retailer's demand in time to ensure that it manages customer relations efficiently – and does not lose any customers. Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology has also introduced automation in inventory management which allows it to improve efficiency and speed, and reduce error rates (Park, 2020; Gillespie & Swan, 2021; Kucuk, 2017).
Transportation
For Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology, this includes choosing cos effective transportation means for inventory handling, as well as order deliveries to customers, as well as retailers. The company uses third-party transportation, as well as manages its own in-house transportation networks for ensuring on-time order deliveries (Abratt & Bendixen, 2018; Chernev, 2018; Grewal & Levy, 2021).
Promotion
The element of promotion in the marketing mix for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology largely refers to the tactics and activities of communication that the company has adopted for promoting its products and services – including the brand, and its offerings, as well as other product features, characteristics, and activities (Varadarajan, 2015; Gillespie & Swan, 2021). The communication is largely targeted toward the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology's target audience and is aimed to increase brand awareness, brand loyalty as well as sales of the company (Wu & Li, 2018; Grewal & Levy, 2021).
Direct marketing
For its more specific products and offerings, Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology uses direct marketing. Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology directly emails potential customers- especially its B2B consumers for detailing its product offerings and features. Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology uses personalized messages and captures new clients and customers for the business. In addition to direct emailing, the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also makes use of telemarketing and direct mail for targeting audiences through direct marketing (Chernev, 2018; Sahaf, 2019).
In-store promotion
Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also focuses on in-store promotions for appealing to the customers, and boosting sales as well as raising brand awareness and profile of its offerings (Baines, Fill, & Rosengren, 2017). For Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology, the in-store promotions include offering price discounts, loyalty points, and flash sales for its products. In addition, the company also invests in building up the POS within the store locations (Stead & Hastings, 2018; Groucutt & Hopkins, 2015).
Social media marketing
One of the more contemporary forms of marketing and promotion for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology includes social media marketing. The company has an official presence and profiles on social media platforms such as Facebook and Instagram, and regularly uses these platforms to promote its offerings, and product features and characteristics (Stead & Hastings, 2018). In addition, these platforms are also used by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to inform consumers about using sales and discounts to increase in-store footfall.
Traditional advertising
The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology continues to use traditional marketing tactics and promotional platforms as well – largely for mass marketing purposes. The company especially focuses on TV advertisements, ad print media advertising for this purpose (Išoraitė, 2016; Iacobucci, 2021).
TV
TV advertisements are generally placed in prime time for higher visibility and reach by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology. The TV advertisements use functional as well as emotional appeals to communicate the message of the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to the audiences (Iacobucci, 2021; Stead & Hastings, 2018).
Print media and advertisements are published in newspapers and magazines – both of which are generally consumed in high proportion by the broader target audience of the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology (Chernev, 2018; Iacobucci, 2021; Stead & Hastings, 2018).
Radio
The Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology also places advertisements on the radio to appeal to a segment of the target population. The radio communications by the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology are usually shorter and focus on functional appeal only (Park, 2020; Išoraitė, 2016; Groucutt & Hopkins, 2015).
Integrated marketing communications
The advertisement and promotional messages by Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology for all mediums and channels however are built on an integrated plan, and ensure that they reflect messages and communication that is similar to the overall campaign to void confusion and discrepancies (Gillespie & Swan, 2021; Kotler & Keller, 2021). The use of integrated marketing and integrated media has allowed the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology to build strong relations with the consumers through prompting conversations and discussions directly with them (Deepak & Jeyakumar, 2019; Sahaf, 2019; Stead & Hastings, 2018).
Conclusion
The 4p model or the marketing mix is an important aspect of brand building and development for the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology and significantly guides the company in the chalking out of its strategic marketing goals and plans. The marketing mix model or the 4P model has helped the Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology in increasing its products’ and services’ reach and penetration and witness high levels of expansion and growth. The model has also led Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology towards a better understanding of its target audience and consumers. This understanding, in turn, has fostered strong emotional relations and increased loyalty on part of consumers towards the company – leading to an overall increase in the brand value and brand equity, as well as higher levels of brand affiliation, brand awareness, and brand recall. Together, the marketing mix has helped the company boost its sales and revenue by aligning its offerings with the needs and demands of the consumers, and the market more effectively and efficiently.
References
Abratt, R., & Bendixen, M. (2018). Strategic marketing: Concepts and cases. New York, United States: Routledge.
Baines, P., Fill, C., & Rosengren, S. (2017). Marketing. New York, United States: Oxford University Press.
Chernev, A. (2018). Strategic marketing management. Berlin/Heidelberg, Germany: Cerebellum Press.
Deepak, R., & Jeyakumar, S. (2019). Marketing management. New Delhi, India: Educreation Publishing.
Gillespie, K., & Swan, K. (2021). Global marketing. New York, United States: Routledge.
Grewal, D., & Levy, M. (2021). M: marketing. New York, United States: McGraw-Hill Education.
Groucutt, J., & Hopkins, C. (2015). Marketing. London: Macmillan International Higher Education.
Iacobucci, D. (2021). Marketing management. Boston, Massachusetts, United States: Cengage Learning.
Išoraitė, M. (2016). Marketing mix theoretical aspects. International Journal of Research-Granthaalayah, 4(6), 25-37.
Kareh, A. (2018). Evolution of the four Ps: Revisiting the marketing mix. Retrieved June 2022, from https://www.forbes.com/sites/forbesagencycouncil/2018/01/03/evolution-of-the-four-ps-revisiting-the-marketing-mix/
Khan, M. (2014). The concept of ‘marketing mix’and its elements. International journal of information, business and management, 6(2), 95-107.
Kotabe, M., & Helsen, K. (2020). Global marketing management. Hoboken, New Jersey, United States: John Wiley & Sons.
Kotler, P., & Keller, K. (2021). Marketing Management (15th global edition). London, United Kingdom: Pearson Education Limited.
Kucuk, S. (2017). Marketing and Marketing Mix. In Visualizing Marketing (pp. 3-7). London, United Kingdom: Palgrave Macmillan.
Park, S. (2020). Marketing management (Vol. 3). Retrieved June 2022, from https://books.google.com.pk/books/about/Marketing_Management.html?id=p6v7DwAAQBAJ&redir_esc=y
Sahaf, A. (2019). Strategic marketing: Making decisions for strategic advantage. New Delhi, India: PHI Learning Pvt. Ltd.
Stead, M., & Hastings, G. (2018). Advertising in the social marketing mix: getting the balance right. In Social Marketing (pp. 29-43). London, England: Psychology Press.
Varadarajan, R. (2015). Strategic marketing, marketing strategy and market strategy. AMS review , 5(3), 78-90.
Wu, Y., & Li, E. (2018). Marketing mix, customer value, and customer loyalty in social commerce: A stimulus-organism-response perspective. Internet Research., 28(1), 74-104.
Related Article
- PESTEL Analysis of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Hofstede Cultural Model of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Net Present Value (NPV) Analysis of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Corporate Social Responsibility of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology Discounted Cash Flow (DCF) Analysis
- VRIO Analysis of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology Case Solution
- Marketing Strategy for Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
- Blue Ocean Strategy of Responding to a Potentially Disruptive Technology How Big Pharma Embraced Biotechnology
Latest Feedback
Barbi Yutong
Verified
Fast response from the writer and the customer support. The prices are suitable and no problem with the timeframe of delivery. Good Job.
Eileen Channon
Verified
The support agent notified me about the completion of the paper. I received the document without even a minute late and was happy after its assessment because the paper was splendid.
Anna Koenig
Verified
My grammar is weak, and it is an essential part of essay writing. I hired this service for the paper and got a splendid assignment. Mr. David (my assigned writer), you are the best writer. May my writing style become like you!
Jordan Emile
Verified
Thank you writer for all of your time that you put in the paper. The proofread assignment was perfect. Highly recommended!
Mark John
Verified
Very quick and excellent service and got me through. The writer followed all my directions, which is why I got an accurate assignment. Thank you so much!
Archie Shane
Verified
The price was really fair; thus, I ordered five assignments here and all of them were properly conducted. I’m really grateful!
Calculate the Price of Your Order
Next Article
- Valeant's Battle for Allergan Marketing Mix
- 1720: John Law and the Mississippi Bubble (A) Marketing Mix
- Xbed: The Dual-Sharing Platform Disrupting China's Hospitality Industry Marketing Mix
- Hubble Contact Lenses: Data Driven Direct-to-Consumer Marketing Marketing Mix
- 1720: John Law and the Mississippi Bubble (B) Marketing Mix
- Standard Chartered Bank Singapore: Embracing the Silver Lining Marketing Mix
- BonaVista Pools: Finding Expertise to Meet Demand Marketing Mix
- Tariffs on Tires (B): The Aftermath Marketing Mix
- Tariffs on Tires (A) Marketing Mix
- Eico: Designed in China Marketing Mix
Previuos Article
- Making the Case Marketing Mix
- Joe Smith's Closing Analysis (B) Marketing Mix
- Joe Smith's Closing Analysis (A), Spanish Version Marketing Mix
- GMAC: The Pipeline Marketing Mix
- On Writing Teaching Notes Well Marketing Mix
- Exxon Corp.: Trouble at Valdez Marketing Mix
- Ashland Oil, Inc.: Trouble at Floreffe (A) Marketing Mix
- Ashland Oil, Inc.: Trouble at Floreffe (B) Marketing Mix
- Ashland Oil, Inc.: Trouble at Floreffe (C) Marketing Mix
- Ashland Oil, Inc.: Trouble at Floreffe (D) Marketing Mix
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire EssayPandas with BIG enough reputation.
Our Guarantees
- Quality assured
- Proof of no plagiarism
- Qualified writers
- Data security
- 24/7 support
- On time delivery
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!
Order Now